Literature DB >> 2535861

T cell receptor beta-chain selection in human allograft rejection.

M C Miceli1, O J Finn.   

Abstract

We have analyzed a series of T cell lines established from renal needle biopsies taken from renal allograft recipients with clinical signs of rejection. These T cells show strong cytotoxicity directed against donor HLA and their proliferative capacity in vitro is highly correlated with irreversible graft rejection. A total of 10 of 12 lines examined by Southern blot analysis using a J beta C beta DNA probe show predominant beta-chain rearrangements. In one instance DNA was isolated from cell lines generated from sequential biopsies taken from the same patient at different times of rejection. These lines show the same predominant beta-chain rearrangements. To determine whether these predominant rearrangements are due to expansion of a single clone or different T cell clones rearranging similar beta-chains, the same blots were analyzed with a J gamma probe. Cell line MH3 shows two predominant beta-chain rearrangements and at least seven of eight possible rearranged gamma-chain bands, implying that multiple clones share similar beta-chains. In contrast, the cell line King shows a single beta-chain and a single gamma-chain rearrangement. Many of the other cell lines fall between these two extremes, indicating that both beta-chain selection and clonal dominance are operating during graft rejection, resulting in the appearance of predominant beta-chain rearrangements.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535861

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  The T-cell-receptor repertoire in the synovial fluid of a patient with rheumatoid arthritis is polyclonal.

Authors:  Y Uematsu; H Wege; A Straus; M Ott; W Bannwarth; J Lanchbury; G Panayi; M Steinmetz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

2.  T cell receptor biases and clonal proliferations among lung transplant recipients with obliterative bronchiolitis.

Authors:  S R Duncan; V Valentine; M Roglic; D J Elias; K W Pekny; J Theodore; D H Kono; A N Theofilopoulos
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

3.  Rejection of cardiac allografts by T cells expressing a restricted repertoire of T-cell receptor V beta genes.

Authors:  H Shirwan; L Barwari; D V Cramer
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

4.  T cell heterogeneity in patients with common variable immunodeficiency as assessed by abnormalities of T cell subpopulations and T cell receptor gene analysis.

Authors:  F Pandolfi; L Trentin; J E San Martin; J T Wong; J T Kurnick; R A Moscicki
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

5.  Restricted V beta gene usage of tumour-infiltrating T lymphocytes in primary gastric malignant B-cell lymphoma.

Authors:  N Yumoto; A Araki; T Sumida; T Saito; M Taniguchi; A Mikata
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Lack of T cell oligoclonality in enzyme-digested synovial tissue and in synovial fluid in most patients with rheumatoid arthritis.

Authors:  J M Van Laar; A M Miltenburg; M J Verdonk; M R Daha; R R De Vries; P J Van den Elsen; F C Breedveld
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

7.  Specific prolongation of allograft survival by a T-cell-receptor-derived peptide.

Authors:  J A Goss; M A Alexander-Miller; J Gorka; M W Flye; J M Connolly; T H Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  Limited clonal heterogeneity of antigen-specific T cells localizing in the pleural space during mycobacterial infection.

Authors:  F Manca; G Rossi; M T Valle; S Lantero; G Li Pira; D Fenoglio; J De Bruin; M Costantini; G Damiani; B Balbi
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

9.  Association of malignant glioma with the human leukocyte antigen, HLA-A24(9).

Authors:  T Nitta; M Ebato; K Sato
Journal:  Neurosurg Rev       Date:  1994       Impact factor: 3.042

10.  T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.

Authors:  J Shilyansky; M I Nishimura; J R Yannelli; Y Kawakami; L S Jacknin; P Charmley; S A Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.